On 30 April, the FluiDx-AD project launched its website, providing information on its activities to advance fluid biomarkers research for Alzheimer’s disease (AD). Alzheimer Europe is pleased to be leading the communication, Public Involvement and Ethics activities as part of the three-and-a-half-year project. The website will be regularly updated with project news, events and results. It also provides an overview of the consortium, objectives and expected outcomes of FluiDx-AD.
Visit the website at: https://www.fluidx-ad.eu/
